Assessing the Gold Standard — Lessons from the History of RCTs
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Randomized, controlled trials have become the gold standard of medical knowledge. Yet their scientific and political history offers lessons about the complexity of medicine and disease and the economic and political forces shaping the production and circulation of knowledge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized clinical trials (RCT) serve as the most valid study design to inform clinical practice according to evidence-based medicine (EBM) principles.1,2”
From Integrity of randomized clinical trials: Performance of integrity tests and checklists requires assessment (2023) · cites this paper as [1]
Citations
Cites
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Zika Virus Infection in Pregnant Women in Rio de Janeiro
Brasil, P., Pereira, J. P., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., Rabello, R. S., Valderramos, S. G., Halai, U.-A., Salles, T. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602412 · Cited by 2,196
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Impure Science: AIDS, Activism, and the Politics of Knowledge
(1997) · Nature Medicine · doi:10.1038/nm0297-242 · Cited by 1,666
The effectiveness of psychotherapy: the Consumer Reports study
Seligman, M. E. P. (1995) · American Psychologist · doi:10.1037/0003-066x.50.12.965 · Cited by 1,608
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366
TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS
Grüntzig, A. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90500-7 · Cited by 1,343
Instruments, Randomization, and Learning about Development
Deaton, A. (2010) · Journal of Economic Literature · doi:10.1257/jel.48.2.424 · Cited by 1,286
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiss, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,277
Research works printed but not linked: 3
- Podolsky SH, Jones DS, Kaptchuk TJ. From trials to trials: blinding, medicine, and honest adjudication. In: Robertson CT, Kesselheim AS, eds. Blinding as a solution to bias: strengthening biomedical science, forensic science, and law. Amsterdam: Elsevier, 2016:45-58.
- Kuo W-H. Japan and Taiwan in the wake of bio-globalization: drugs, race and standards (Ph.D. dissertation). Cambridge: Massachusetts Institute of Technology, 2005.
- Rothman DJ, 2000, New York Rev Books, 47, 60
Cited by
Items 401–500 of 698
The New Modern Medicine: Disease, Evidence, and Epidemiological Medicine
Fuller, J. (2025) · doi:10.1093/9780190066178.001.0001 · Cited by 7
Nebivolol in the therapeutic landscape of heart failure: Mechanisms and clinical outcomes
Ginghina, E. R., Biondi‐Zoccai, G., Vitali, A., Napoli, L. F. D., & Frati, G. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107562 · Cited by 3
Hall, S. S., Hall, C., Partlett, C., Jeayes, A., Rattu, N. R., Henshaw, H., Martin, J., & Shoesmith, E. (2026) · PLOS Digital Health · doi:10.1371/journal.pdig.0001466 · Cited by 3
“Randomised Controlled Trials (RCTs) are regarded as the ‘gold standard’ for evaluating healthcare interventions [7], but their reliance on selective samples and inadequate demographic reporting [8–10],limits real-world applicability and produces a skewed data base on which decisions are made…”
Análisis de homologías y heterogeneidad entre congresos de Reumatología: mexicanos, ACR y EULAR
Cuevas-Orta, E., Pedro-Martínez, Á. J., Ramírez-Rodríguez, C., & Abud‐Mendoza, C. (2018) · Reumatología Clínica · doi:10.1016/j.reuma.2018.04.002 · Cited by 3
“LES CMR 44 3 (5) 0 9 (15) 34 (56,6) 3 (5) 3 (5) 8 (13,3) 60 (21,8) CMR 45 1 (1,3) 0 7 (9,3) 43 (57,3) 12 (16) 8 (10,6) 4 (5,3) 75 (22) ACR 8 (2,1) 49 (12,8) 81 (21,3) 101 (26,5) 38 (10) 77 (20,2) 26 (6,8) 380 (11,6)”
Long, C., Azad, A. D., desJardins-Park, H. E., & Fox, P. M. (2018) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000005366 · Cited by 3
“Mendelian Randomization” Approach in Economic Assessment of Health Conditions
Gupta, V., SACHDEVA, M. P., & Walia, G. K. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00002 · Cited by 3
“Appropriately designed randomized controlled trials (RCTs), where study participants are randomly assigned to the intervention and control groups, are considered as gold standard in detecting the causal evidence (19).”
BackgroundHandan‐Nader, C., Ho, D. E., & Elias, B. (2020) · Evaluation Review · doi:10.1177/0193841x20930852 · Cited by 3
“Many perceive RCTs as slow and expensive (Bothwell et al., 2016).”
BackgroundAnderson, B., Dudla, S., Marantz, P. R., Kligler, B., Leininger, B. D., & Evans, R. (2021) · BMC Medical Education · doi:10.1186/s12909-021-02690-z · Cited by 3
“Problems associated with the validity of this clinical trial methodology have been widely discussed in the literature for both TCIM therapies [29, 34, 36, 37] and biomedicine [38].”
BackgroundThe Pragmatic Turn in Clinical Research
Zvonareva, O. (2021) · Science & Technology Studies · doi:10.23987/sts.92043 · Cited by 4
“Concerns about how knowledge obtained in clinical trials applies to the treatment of patients have accompanied the very rise of the randomised controlled trial (RCT), which has been the key method of evaluating medical interventions since the 1960s, particularly pharmaceuticals (Bothwell et al., 2016; Cartwright, 2007…”
MethodAbdalla, M., Abdalla, M., Abdalla, S., Saad, M., Jones, D. S., & Podolsky, S. H. (2022) · eLife · doi:10.7554/elife.72602 · Cited by 3
“Even more strikingly, we see (Figure 2e and f) the rise of the clinical trial infrastructure and the epistemic grounding of medical science within such trials (Bothwell et al., 2016), reflected in the rise of ‘controlled’ and ‘randomized’, and still more dramatically, of ‘trial’ itself (with a corresponding decline in…”
BackgroundSelf-citationYu, X., Wang, L., Wang, L., Wang, Y., Wang, Y., Xin, S., Lei, G., Zhao, S., Chen, Y., Guo, X., et al. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01787-3 · Cited by 3
“However, there remain substantial variations in realworld transfusion practice because of an unmet need for further evidence, slow evidence generation, and limited patient representativeness using RCT design being a bottleneck [5].”
BackgroundEcosystem of Patient-Centered Research and Information System Design
Hsueh, P.-Y. S. (2022) · Cognitive informatics in biomedicine and healthcare · doi:10.1007/978-3-031-07696-1_16 · Cited by 5
Wathen, J. K., Jagannatha, S., Ness, S. L., Bangerter, A., & Pandina, G. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101061 · Cited by 3
Experimental approach to development economics: a review of issues and options
Sekhar, C. S. C., & Thapa, N. (2024) · Journal of Economic Methodology · doi:10.1080/1350178x.2024.2341292 · Cited by 5
“(b) More replications : It is uncommon for researchers to replicate RCTs or check their validity across geographies because of the high costs of RCTs (Bothwell et al., 2016).”
BackgroundWelsh, B. C., Zane, S. N., & Podolsky, S. H. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197675946.001.0001 · Cited by 3
Self-citationIntelligent Tinkering in Climate Change Adaptation
Zommers, Z. A., & Alverson, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811891-7.00027-x · Cited by 3
Geriatric pharmacotherapy: Appraising new drugs for neurologic disorders in older patients
Seeman, M. V., Becker, R. E., & Greig, N. H. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00001-7 · Cited by 3
Teuscher (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170710dt · Cited by 4
Do we need to reconsider how we design and conduct randomized controlled trials?
Batra, G., & Wallentin, L. C. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcac010 · Cited by 3
Xiong, X., Lv, G., Jiang, B., & Lu, K. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1129399 · Cited by 4
“However, in RCTs, the setting is rigorous, and the strict inclusion and exclusion criteria for patients may affect the external study of their findings (6, 8).”
BackgroundWhen will we have enough evidence to require improvements at the workplace?
Alex Burdorf, A. (2024) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.4199 · Cited by 3
Yun, Q., Lin, M. C., Jia, Y., Wang, Y., Zhang, J., Sha, F., Yang, Z., & Tang, J.-L. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111265 · Cited by 2
Pellat, A., Boutron, I., Perrodeau, É., Porcher, R., Tran, V.-T., & Ravaud, P. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111482 · Cited by 2
Advancing Equitable Participation in Pediatric Clinical Trials Through Cognitive Interviewing
Ryan, G. W., Goulding, M., Agudelo, D. M., Simms, S., Spano, M. A., Arenas, J., Becker, S., Radu, S., Lemon, S. C., Rosal, M. C., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2024-068666 · Cited by 2
Rae, K. E., Barker, J., Upton, D., & Isbel, S. T. (2025) · Nursing Reports · doi:10.3390/nursrep15030111 · Cited by 2
“This reflects a broader issue in non-pharmaceutical randomised-controlled trials, where achieving adequate sample size is challenging [5,62], further bringing into question the emphasis on the explanatory design.”
Patient preference trials in oncology: a scoping review and recommendations on reporting
Kamp, D., Kessels, R., Mohammad, N. H., Schmitz, R., IntHout, J., van Laarhoven, H. W. M., May, A. M., & Groenwold, R. H. H. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111837 · Cited by 2
Xie, T., Hao, Y., & Xie, F. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1647200 · Cited by 2
“Randomized controlled trials (RCTs), which are considered the gold standard for causal inference, were later proposed by researchers but are challenging to implement in sports science (14), particularly in elite sports (15).”
Holman, B., & Sung, D. (2025) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197625835.013.0020 · Cited by 2
A bayesian dynamic borrowing framework for improving the efficiency of clinical trials
Zheng, Z., Chen, K., Zhu, P., Wu, H., Jiang, S., Zhang, D., Chow, S., & Wu, Y. (2025) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02691-2 · Cited by 2
“Additionally, the inherent shortcomings of randomized controlled trials (RCT) are driving a growing interest in obtaining confirmatory real-world evidence [2, 3].”
How to improve statistical power in a trial with SCA2 patients using natural history data
Tran, M., Poulet, P., Petit, E., Dürr, A., Klockgether, T., Ashizawa, T., Coarelli, G., & du Montcel, S. T. (2026) · Trials · doi:10.1186/s13063-026-09591-w · Cited by 2
“By the early 1980 s, clinical epidemiologists have regarded RCTs as the highest level of medical evidence [1].”
Kristensen, A. M. D., Jortveit, J., Holmager, T. L. F., Atar, D., Olsen, M. H., Bakken, A., Steigen, T. K., Schirmer, H., Edvardsen, T., Larsen, A. I., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag348 · Cited by 2
Ethics in Palliative Care Research
Raus, K., & Sterckx, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-77740-5_110 · Cited by 2
Undue Pharmaceutical Industry Influence in Medical Profession
Laskai, A. (2020) · Studies of organized crime · doi:10.1007/978-3-030-44790-8_2 · Cited by 2
Placeboeffekte in der Schmerztherapie
Klinger, R., Schwartz, M., & Bingel, U. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00942-9 · Cited by 3
Xiong, G. X., Kang, J. R., Sharma, J., Finlay, A. K., Gardner, M. J., & Bishop, J. A. (2021) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-021-03051-8 · Cited by 2
Lerner, B. H., & Curtiss-Rowlands, G. (2022) · Milbank Quarterly · doi:10.1111/1468-0009.12583 · Cited by 2
Meireles, A. L. F., Menegol, N. A., Perin, G. A., & Sanada, L. S. (2023) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000576 · Cited by 3
King, A., Thompson, J.-A., Hart, S., & Nossaman, B. D. (2024) · Southern Medical Journal · doi:10.14423/smj.0000000000001722 · Cited by 2
Evidence for the Efficacy of COVID-19 Convalescent Plasma
Klassen, S. A., & Senefeld, J. W. (2024) · Current topics in microbiology and immunology · doi:10.1007/82_2024_280 · Cited by 2
‘Worm Wars’: The Unravelling of the Randomised Control Trial Success Story
Vanderslott, S. (2024) · Engaging Science Technology and Society · doi:10.17351/ests2023.1469 · Cited by 2
Navigating complexity: a pattern language approach for behavioral science in public policy
Stenger, K., & Schmidt, R. (2025) · Behavioural Public Policy · doi:10.1017/bpp.2024.47 · Cited by 2
Yu, X., Chen, Y., & Podolsky, S. H. (2025) · Journal of the Royal Society of Medicine · doi:10.1177/01410768251337693 · Cited by 2
Self-citationThe Basis of Atherosclerotic Guidelines—Time for a Change?
Schade, D. S., & Eaton, R. P. (2018) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2018.87033 · Cited by 2
“In many circumstances, it is also cost effective, preventing the high cost of invasive long-term cardiovascular medical care [50].”
BackgroundThe value of participating in clinical trials: the whole is greater than the sum of its parts
Zalcberg, J. R., & Friedlander, M. L. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.01266 · Cited by 2
Level 1 Evidence: A Prospective Randomized Controlled Study
Ekhtiari, S., Mundi, R., Khanna, V., & Bhandari, M. (2019) · Springer eBooks · doi:10.1007/978-3-662-58254-1_29 · Cited by 2
Evidence-Based Medicine in the Domain of Nuclear Medicine, the Fifty-Year View
Zuckier, L. S. (2019) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2019.07.007 · Cited by 2
Optimizing clinical trial design using prospective cohort study data: a case study in neuro-urology
Anderson, C. E., Birkhäuser, V., Stalder, S. A., Bachmann, L. M., Curt, A. E. P., Jordan, X., Leitner, L., Liechti, M. D., Mehnert, U., Mohr, S. N., et al. (2020) · Spinal Cord · doi:10.1038/s41393-020-00588-z · Cited by 3
“Randomized controlled trials (RCTs) are often considered the “gold standard” for producing decisive evidence regarding intervention efficacy, but they are also challenging to execute [1].”
BackgroundEthics in Palliative Care Research
Raus, K., & Sterckx, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-31738-0_110-1 · Cited by 2
A case for conducting business-to-business experiments with multi-arm multi-stage adaptive designs
Legare, J., Yao, P., & Lo, V. S. Y. (2022) · Journal of Marketing Analytics · doi:10.1057/s41270-022-00177-4 · Cited by 3
“Randomized Controlled Trials (RCTs) are the classic experimental design, widely used for measuring the effectiveness of a novel treatment over a control, and prized for their robust, refined designs which help limit statistical biases (Bothwell et al. 2016).”
MethodYoung, J., Widdowson, M., & Tate, D. (2023) · Counselling and Psychotherapy Research · doi:10.1002/capr.12651 · Cited by 2
Marsney, R. E. L., Johnson, K. E., Flores, J. C., Coetzer, S., Darvas, J., Delzoppo, C., Jolly, A., Masterson, K., Sherring, C. L., Thomson, H. M., et al. (2024) · Clinical Trials · doi:10.1177/17407745231222019 · Cited by 2
Results from the BRIOS randomised trial – Authors' reply
Mullender, M. G., Dikmans, R. E. G., Negenborn, V. L., Ruhé, P. Q., Mureau, M. A. M., & Bouman, M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30161-4 · Cited by 2
Positive about negative: no need for a pink cloud of fluff and justifications
Albrecht, J., Kirtschig, G., Matin, R., Samimi, M., & Batchelor, J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15644 · Cited by 2
Talking about mental health nursing: a qualitative analysis of nurses’ and service users’ accounts
Terry, J. (2018) · Cronfa (Swansea University) · doi:10.23889/suthesis.43230 · Cited by 2
Tettelbach, W. H. (2019) · International Wound Journal · doi:10.1111/iwj.13089 · Cited by 2
“The randomised controlled trial (RCT) is a research methodology that reduces bias and enhances the accuracy of clinical experimentation while producing generalisable, universal biomedical knowledge.(2) To that end, the RCT methodology is considered the “gold standard” study design to generate the highest level of clin…”
MethodSleep surgery improves blood pressure: How can it be?
Weaver, E. M. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101619 · Cited by 2
Causal Inference in Psychological CapitalPreprint
Yang, L. P. H. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/tcvfm · Cited by 2
Randomization Bias, Multi-Morbidity, and the Composite Clinical Score
Horwitz, R. I., Baker, J. B., Ghatak, A., & Cullen, M. R. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000539522 · Cited by 2
“Randomization “ Bias ” (Validity) Clinical trialists often suggest that RCTs are the “ gold standard ” for evaluating the potential bene fi ts of new or existing medicines and devices [6].”
Current Trends in the Applications of Probiotics and Other Beneficial Microbes: Expanding Horizons
Fijan, S., & Fijan, T. (2025) · Applied Microbiology · doi:10.3390/applmicrobiol5040103 · Cited by 2
“Together, these various methodologies enable new biologically plausible and clinically meaningful knowledge about beneficial microbes [16–18].”
Global Ambitions: Evidence, Scale, and Child Well‐being in El Salvador
Matza, T. (2019) · Medical Anthropology Quarterly · doi:10.1111/maq.12505 · Cited by 1
Zhao, L. C., Blasdel, G., Parker, A. C., & Bluebond‐Langner, R. (2023) · The AMA Journal of Ethic · doi:10.1001/amajethics.2023.391 · Cited by 2
Samad, M., Sutherland, M., Ganier, D., Broussard, D. M., Koveleskie, J., Nossaman, V. E., & Nossaman, B. D. (2024) · Journal of Perioperative Practice · doi:10.1177/17504589241267859 · Cited by 1
Lawand, J. J., Hantouly, A. T., Bouri, F., Muneer, M., & Hagert, E. M. (2024) · Journal of Hand Surgery Global Online · doi:10.1016/j.jhsg.2024.08.007 · Cited by 1
Hermann, L. L., Arundel, C., Thomas, A., Twiddy, M., & Clark, L. (2024) · Research Methods in Medicine & Health Sciences · doi:10.1177/26320843241289094 · Cited by 2
Narahari, A. K., Horgan, T. M., Chandrabhatla, A. S., Kareddy, A., Gikandi, A., Zenati, M. A., Harpole, D. H., Jones, D., Yarboro, L. T., Burt, B. M., et al. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.09.053 · Cited by 1
Self-citationShimizu, Y., Hanazawa, R., Sato, H., & Hirakawa, A. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101450 · Cited by 1
“However, this traditional approach, although straightforward, leads to the proliferation of individual RCTs for each investigational drug, resulting in prolonged drug development timelines, inflated patient enrollment, and a narrow focus on scientific inquiries [4,5].”
de Souza, N. F. S., Broekema, A. E. H., Soer, R., Tamási, K., van Asselt, A. D. I., Reneman, M., van Dijk, J. M. C., & Kuijlen, J. M. A. (2025) · The Spine Journal · doi:10.1016/j.spinee.2025.03.002 · Cited by 1
author, & Rao, K. V. (2025) · INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT · doi:10.55041/ijsrem48111 · Cited by 1
Choufani, M., Ermann, J., & Goel, N. (2025) · Arthritis Care & Research · doi:10.1002/acr.25574 · Cited by 1
Rao, S. (2025) · INNOVAPATH · doi:10.63501/xptwta38 · Cited by 1
“The practice of evidence-based medicine is anchored in the integrity and rigor of prospective interventional clinical trials, which are considered the gold standard for determining the safety and efficacy of medical interventions (Bothwell, Greene, Podolsky, & Jones, 2016).”
Fehr, F. C., Stevens, N., Hailey, J. R. T., Lo, L. A., Pistawka, C. A., & MacCallum, C. A. (2025) · Journal of Child Health Care · doi:10.1177/13674935251350177 · Cited by 2
“However, there are signi fi cant drawbacks to depending on this type of evidence (Bothwell et al., 2016).”
Yang, J., Wang, D., Han, Y., Tan, X., & Du, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-03515-x · Cited by 1
“Although randomized controlled trials (RCTs) are considered the ‘gold standard’ for examining causal relationships between diseases, but their high cost and extended time-frames often limit their effectiveness in identifying cancer risk factors [10].”
Pillitteri, G., Clemente, F. M., Petrucci, M., Sarmento, H., Figueiredo, A. J., Bongiovanni, T., Bianco, A., Battaglia, G., & Gabbett, T. J. (2025) · Biology of Sport · doi:10.5114/biolsport.2025.151660 · Cited by 2
“…studies have been carried out to un - derstand sport injuries, we highlight that the literature is lacking RCTs—commonly regarded as the ‘gold standard’ for assessing cau - sality [143], as this type of study makes it possible to eliminate the effects of confounding variables [20, 143].”
Liu, X., Wang, H., Zhao, Q., Wang, R., & Cao, H. (2025) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2025.10.002 · Cited by 1
Jaffe, K., Jutras‐Aswad, D., & Richardson, L. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118697 · Cited by 1
Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic
Vural, İ. E., Herder, M., & Graham, J. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118759 · Cited by 1
Yu, X., Wang, Z., Wang, L., Huang, Y., Wang, Y., Xin, S., Lei, G., Zhao, S., Chen, Y., Guo, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550892 · Cited by 1
Yang, Y., Chen, M., Hu, W., Fu, Y., Li, X., Liao, Z., Feng, H., Zhao, Y., Pei, L., Mi, B., et al. (2026) · Journal of Medical Internet Research · doi:10.2196/78492 · Cited by 1
“This warrants further studies with stronger causal evidence, such as randomized controlled trials [34,35].”
Barriers to Adopting Evidence From Bayesian Adaptive Clinical Trials in Critical Care
Malley, B. E., Levin, J. M., Kahn, J. M., Bukowski, L. A., & Huang, D. T. (2026) · CHEST Critical Care · doi:10.1016/j.chstcc.2026.100264 · Cited by 1
Sørensen, J. K., Mathisen, J., Pedersen, J., Burr, H., Holm, A., Lallukka, T. M., Melchior, M., Rod, N. H., Rugulies, R., Sivertsen, B., et al. (2026) · International Journal of Public Health · doi:10.3389/ijph.2026.1609400 · Cited by 1
“However, conducting randomized trials within a work environment setting is often impossible, both ethically and in terms of feasibility [20, 21].”
Raynaud, M., Trayanova, N. A., Mannon, R. B., André, F., Doraiswamy, P. M., & Loupy, A. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-026-00487-7 · Cited by 2
Applying Evidence From Clinical Trials: Need for Pediatric Learning Health System Research
Mistry, K. B., & Forrest, C. B. (2017) · PEDIATRICS · doi:10.1542/peds.2017-3098 · Cited by 1
Duval, J.-L., Coulson, M., Merriman, R. C., Kumar, R., & Turakhia, M. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003414 · Cited by 1
Critical appraisal of clinical trials in oncology — part I
Kaczor, M. P., Wójcik, R., Połowinczak-Przybyłek, J., & Potemski, P. (2019) · Oncology in Clinical Practice · doi:10.5603/ocp.2018.0057 · Cited by 1
“Correctly designed and conducted, blinded, randomised clinical trials (RCTs) provide evidence with the highest level of credibility [2].”
BackgroundMore Than a Manufacturer: The Role of Industry in Medicine
Laskai, A. (2020) · Studies of organized crime · doi:10.1007/978-3-030-44790-8_5 · Cited by 1
The Dilemma of Outsourcing Drug Trials
Barat, S. (2020) · ATHENS JOURNAL OF HEALTH & MEDICAL SCIENCES · doi:10.30958/ajhms.7-2-2 · Cited by 1
Innovations in Systemic Family Therapy Effectiveness Research
Miller, R. B., & Jaurequi, M. E. (2020) · Wiley eBooks · doi:10.1002/9781119790181.ch19 · Cited by 1
Endolymphatic Sac Surgery: Understanding the Historical Influence of Circumstance and Statistics
Hamza, M. M., Huang, V. W., & Naples, J. G. (2022) · Otolaryngology · doi:10.1177/01945998221116563 · Cited by 1
Podolsky, S. H. (2023) · Journal of the Royal Society of Medicine · doi:10.1177/01410768231183241 · Cited by 1
“based studies would eventually be the pharmaceutical industry itself.(55) While the shape of individual studies”
Self-citationToraman, S., Merianos, A. L., Stone, L., Schnadower, D., Bouvay, K. L., & Mahabee‐Gittens, E. M. (2023) · Toxics · doi:10.3390/toxics11080655 · Cited by 1
“This is because RCTs allow investigators to examine causal relationships between interventions and outcomes by eliminating much of the bias inherent in other study designs [1,2].”
BackgroundMajlesara, A., Aminizadeh, E., Ramouz, A., Khajeh, E., Shahrbaf, M., Borges, F., Gonçalves, G., Carvalho, C. T., Golriz, M., & Mehrabi, A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14210 · Cited by 1
COVID-19 platform trials: insight and lessons in clinical trial design
New, J. M., Chalmers, J. D., & Stobo, J. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10021223 · Cited by 1
Shi, M., Wang, T., Xie, Q., Yuan, G., Xia, J., Yang, J., Xie, W., Chen, Z., & Chen, X. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2498106 · Cited by 1
“However, RCTs can be costly, time-consuming, and, in many cases, ethically or practically infeasible [34].”
Cluster-Based Insights into Cardiovascular and Autonomic Responses to Head-Up Tilt in Hypertension
Ooi, J. H., Goh, C., Argha, A., Tan, M. P., Beh, H. C., Sari, N. A. M., Lovell, N. H., & Lim, E. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109202 · Cited by 1
Re: A History of Pivotal Advances in Clinical Research Into Bone and Mineral Diseases
Miller, P. D., Bilezikian, J. P., Lewiecki, E. M., Watts, N. B., & CAREY, J. J. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3566 · Cited by 1
Inferring causation from big data in the social sciences
Ghiara, V. (2019) · Kent Academic Repository (University of Kent) · Cited by 3
Chau, I., Le, D. T., Ott, P. A., Korytowsky, B., Le, H., Le, T. K., Zhang, Y., Sánchez, T., Maglinte, G. A., Laurie, M., et al. (2019) · Gastric Cancer · doi:10.1007/s10120-019-01021-y · Cited by 1
The natural sciences in the information systems research literature: Correcting misinterpretations
Myers, M. D. (2020) · Journal of Information Technology · doi:10.1177/0268396220945715 · Cited by 1
New Non-Validated Practice: An Enhanced Definition of Innovative Practice for MedicinePreprint
Mastroleo, I., & Holzer, F. (2019) · Preprints.org · doi:10.20944/preprints201905.0070.v2 · Cited by 1
“In fact, from a point of view of evidence-based medicine, “RCTs have never monopolized medical knowledge production” (Bothwell et al. 2016).”
BackgroundAdaptive designs for clinical trials
Nirmalan, P. K. (2021) · Kerala Journal of Ophthalmology · doi:10.4103/kjo.kjo_202_20 · Cited by 1
Metadata
- Authors
- Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-06-02
- Volume
- 374
- Issue
- 22
- Pages
- 2175-2181
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2413861456
- Cited by
- 664
- References
- 54
- Citations by year
- 2026: 40 · 2025: 101 · 2024: 59 · 2023: 53 · 2022: 49 · 2021: 76 · 2020: 93 · 2019: 71 · 2018: 74 · 2017: 43 · 2016: 5
- FWCI
- 337.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Arts and Humanities › History and Philosophy of Science › History of Science and Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Keywords
- randomized controlled trials, history of medicine, evidence-based medicine, scientific knowledge production, medical politics, health research funding
- MeSH terms
- Drug Industry, Female, Humans, Legislation, Drug, Pregnancy, Randomized Controlled Trials as Topic, Drug Approval, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.